Michael Paul North - Feb 17, 2022 Form 4 Insider Report for AMEDISYS INC (AMED)

Role: Chief Information Officer
Signature: /s/ Jennifer R. Guckert, pursuant to a power of attorney
Stock symbol: AMED
Transactions as of: Feb 17, 2022
Transactions value $: -$163,077
Form type: 4
Date filed: 2/22/2022, 08:07 PM
Next filing: Feb 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMED	Common Stock	Award	$0	+1.31K	+14.49%	$0.00	10.3K	Feb 17, 2022	Direct	F1, F2
transaction	AMED	Common Stock	Tax liability	-$163K	-1.16K	-11.18%	$141.07	9.19K	Feb 20, 2022	Direct	F2
holding	AMED	Common Stock						457	Feb 17, 2022	Through 401(k) Plan	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMED	Stock Option (Right to Buy)	Award	$0	+3.06K		$0.00	3.06K	Feb 17, 2022	Common Stock	3.06K	$143.25	Direct	F4
transaction	AMED	Restricted Share Units (Performance-Based Vesting)	Award	$0	+2.62K		$0.00	2.62K	Feb 17, 2022	Common Stock	2.62K		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer awarded the Reporting Person 1,309 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of February 20, 2023, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
F2	The total amount of shares beneficially owned includes 1,247 shares held in an employee stock purchase plan account.
F3	The information in this report is based on a plan statement dated as of December 31, 2021.
F4	The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of February 20, 2023, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
F5	The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2022, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2024, 2025 and 2026, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.